Compare Mutual Funds
Select a Mutual Fund
Risk | Very High | - |
Rating | - | - |
Min SIP Amount | ₹100 | - |
Expense Ratio | 1.12 | - |
NAV | ₹12.25 | - |
Fund Started | 08 Apr 2024 | - |
Fund Size | ₹158.82 Cr | - |
Exit Load | Exit load of 0.25%, if redeemed within 15 days. | - |
Risk
Very High
-
Rating
-
-
Min SIP Amount
₹100
-
Expense Ratio
1.12
-
NAV
₹12.25
-
Fund Started
08 Apr 2024
-
Fund Size
₹158.82 Cr
-
Exit Load
Exit load of 0.25%, if redeemed within 15 days.
-
1 Year | 1.60% | - |
3 Year | - | - |
5 Year | - | - |
1 Year
1.60%
-
3 Year
-
-
5 Year
-
-
Equity | 100.06% | - |
Cash | -0.06% | - |
Equity
100.06%
-
Cash
-0.06%
-
Top 10 Holdings |
| - |
Top 10 Holdings
Lupin Ltd. | 9.51% |
Fortis Healthcare Ltd. | 8.56% |
Laurus Labs Ltd. | 8.00% |
Aurobindo Pharma Ltd. | 6.15% |
Alkem Laboratories Ltd. | 5.99% |
Glenmark Pharmaceuticals Ltd. | 5.70% |
Mankind Pharma Ltd. | 4.62% |
Biocon Ltd. | 4.40% |
Ipca Laboratories Ltd. | 3.67% |
Abbott India Ltd. | 2.82% |
-
Name | - | - |
Start Date | - | - |
Name
-
-
Start Date
-
-
Description | The scheme seeks to provide returns, before expenses, that are in line with the performance of Nifty MidSmall Healthcare Index (TRI), subject to tracking error. | - |
Launch Date | 08 Apr 2024 | - |
Description
The scheme seeks to provide returns, before expenses, that are in line with the performance of Nifty MidSmall Healthcare Index (TRI), subject to tracking error.
-
Launch Date
08 Apr 2024
-